Ganciclovir
Ganciclovir, ZIRGAN
Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor
NADAC/unit
$91.3820
No Shortage
Tier 1: 12.2%
5 Manufacturers
5 ANDAs
vs. brand Ganciclovir: Generic saves up to -814% per unit
Market Intelligence
2023-01-04 Class II Recall: Hikma Pharmaceuticals USA Inc.
Generic Manufacturers
BAUSCH AND LOMB INCFRESENIUS KABI USA LLCHIKMA PHARMACEUTICALS USA INCPH HEALTH LTDPHARMASCIENCE INCSLATE RUN PHARMACEUTICALS LLC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.